Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker. Issue 11 (16th September 2021)

• Record Type: Journal Article
• Authors: Pacheco, Christine; Wei, Janet; Shufelt, Chrisandra; C. Hitzeman, Tara; Cook‐Wiens, Galen; Pepine, Carl J.; Handberg, Eileen; Anderson, R. David; Petersen, John; Hong, TingTing; M. Shaw, Robin; Bairey Merz, C. Noel
• Is Part Of: Clinical cardiology. Volume 44:Issue 11(2021)
• Page Start: 1586
• Page End: 1593
• Publication Date: 2021-09-16
• Subjects: coronary microvascular dysfunction -- heart failure -- women; Cardiology -- Periodicals; 616.12005
• DOI: 10.1002/clc.23726
• Languages: English
• ISSNs: 0160-9289

Abstract

Abstract: Background: Coronary microvascular dysfunction (CMD) is associated with heart failure with preserved ejection fraction (HFpEF); however, pathophysiology is not well described. Hypothesis: We hypothesized that CMD in women with suspected ischemia with no obstructive coronary artery disease (INOCA) is associated with cardiomyocyte dysfunction reflected by plasma levels of a cardiomyocyte calcium handling protein, cardiac bridge integrator 1 (cBIN1). Methods: Women with suspected INOCA undergoing coronary function testing were included. Coronary flow reserve, vasodilation to nitroglycerin, change in coronary blood flow (ΔCBF), and vasodilation to acetylcholine (ΔAch) were evaluated. cBIN1 score (CS) levels in these women (n = 39) were compared to women with HFpEF (n = 20), heart failure with reduced ejection fraction (HFrEF) (n = 36), and reference controls (RC) (n = 50). Higher CS indicates cardiomyocyte tubule dysfunction. Results: INOCA, HFpEF, and HFrEF women were older than RC ( p < .05). Higher CS was associated with vasoconstriction to acetylcholine (r = −0.43, p = .011) with a trend towards lower ΔCBF (r = 0.30, p = .086). Higher CS was specific for ΔAch and ΔCBF but had limited sensitivity. INOCA women had higher CS than RC, but lower CS than HFpEF/HFrEF groups ( p < .001). Conclusions: CS, a plasma biomarker indicating poor cardiomyocyte health, was higher in women with suspected INOCA as compared to RC, but lower than in women with HFpEF. Elevated CS in suspected INOCA patients represents an intermediate group between health and disease, supporting the hypothesis that CMD may progress to HFpEF. Larger prospective cohort studies are needed to confirm the pathophysiological relationship between cBIN1, CMD, and HFpEF.